Concurrent KRAS p.G12C mutation and ANK3::RET fusion in a patient with metastatic colorectal cancer: a case report
Abstract Background Colorectal cancer (CRC) frequently involves mutations in the KRAS gene, impacting therapeutic strategies and prognosis. The occurrence of KRAS mutations typically precludes the presence of RET fusions, with current medical literature suggesting a mutual exclusivity between these...
Saved in:
Main Authors: | Tillmann Bedau (Author), Carina Heydt (Author), Udo Siebolts (Author), Thomas Zander (Author), Max Kraemer (Author), Heike Loeser (Author), Reinhard Buettner (Author), Alexander Quaas (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2024-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
RET inhibition in novel patient-derived models of RET fusion- positive lung adenocarcinoma reveals a role for MYC upregulation
by: Takuo Hayashi, et al.
Published: (2021) -
EGFR-mutated pulmonary adenocarcinoma with concurrent PIK3CA mutation, and with acquired RET fusion and EGFR T790M mutation after afatinib therapy
by: Minhye Kim, et al.
Published: (2021) -
Concurrent Targeting of KRAS and AKT by MiR-4689 Is a Novel Treatment Against Mutant KRAS Colorectal Cancer
by: Masayuki Hiraki, et al.
Published: (2015) -
Ret-dependent and Ret-independent mechanisms of Gfl-induced sensitization
by: Meadows Rena M, et al.
Published: (2011) -
Molecular Profiling of Odontogenic Tumors - Pilot Study
by: Gültekin Sibel Elif, et al.
Published: (2017)